Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: Are the Visual Outcomes Different From Giant Cell Arteritis? Comment on the Article by Delaval et al
- 18 February 2021
- journal article
- letter
- Published by Wiley in Arthritis & Rheumatology
- Vol. 73 (7), 1345-1346
- https://doi.org/10.1002/art.41698
Abstract
The article by Delaval et al. beautifully highlighted the differences between clinical manifestations and temporal artery biopsy (TAB) in TA‐AAV and GCA patients [1]. However, the differences in visual outcomes, if any, were not reported. Since visual outcomes in GCA are generally poor and can progress despite treatment, it would be interesting to know the visual outcomes in these patients[2, 3]. Two of our patients with early TA‐AAV had good visual outcomes with treatment.This publication has 3 references indexed in Scilit:
- Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control StudyArthritis & Rheumatology, 2021
- Poor Prognosis of Visual Outcome after Visual Loss from Giant Cell ArteritisOphthalmology, 2005
- Recovery of visual function in patients with biopsy-proven giant cell arteritisOphthalmology, 2003